Supraclavicular Brachial Plexus Block Using Ropivacaine Alone and With Dexmedetomidine
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
80 American Society of Anesthesiologists (ASA) grade I-II patients, 18-60 years old,scheduled
for elective upper limb orthopaedic surgery under supraclavicular brachial plexus block, were
included in this prospective study. The patients were randomly assigned to group R
(Ropivacaine alone) and group RD (Ropivacaine and dexmedetomidine) (40 patients in each
group). Group R received Ropivacaine 0.50% (30 cc) + placebo and group RD received
Ropivacaine 0.50% (30 cc) + dexmedetomidine 1 µg/kg.